Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.143 USD | -2.05% | -7.74% | -26.67% |
04-15 | CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
03-05 | Transcript : CytoDyn Inc. - Special Call |
Sales 2022 | 0.27 0.36 | Sales 2023 | - | Capitalization | 239M 327M |
---|---|---|---|---|---|
Net income 2022 | -211M -288M | Net income 2023 | -79M -108M | EV / Sales 2022 | 989,524,989 x |
Net Debt 2022 | 32.57M 44.51M | Net Debt 2023 | 33.01M 45.12M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.02
x | P/E ratio 2023 |
-2.52
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.15% |
Latest transcript on CytoDyn Inc.
1 day | -2.05% | ||
1 week | -7.74% | ||
Current month | -12.43% | ||
1 month | -13.33% | ||
3 months | -11.35% | ||
6 months | -20.56% | ||
Current year | -26.67% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 11-16 | |
Mitchell Cohen
DFI | Director of Finance/CFO | 68 | 01-31 |
Scott Hansen
CTO | Chief Tech/Sci/R&D Officer | - | 23-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Simes
BRD | Director/Board Member | 72 | 22-10-12 |
Ryan Dunlap
BRD | Director/Board Member | 54 | 22-08-23 |
Karen Brunke
BRD | Director/Board Member | 72 | 22-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.143 | -2.05% | 2,217,125 |
24-04-25 | 0.146 | -1.68% | 420,675 |
24-04-24 | 0.1485 | -1.00% | 648,615 |
24-04-23 | 0.15 | -0.07% | 423,580 |
24-04-22 | 0.1501 | -3.16% | 790,017 |
Delayed Quote OTC Markets, April 26, 2024 at 03:59 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-26.67% | 142M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- CYDY Stock